BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su Y, Zhang Y, Chen M, Jiang Z, Sun L, Wang T, Zhang L. Lipopolysaccharide exposure augments isoniazide-induced liver injury. J Appl Toxicol 2014;34:1436-42. [PMID: 25331106 DOI: 10.1002/jat.2979] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Hassan HM, Guo H, Yousef BA, Luyong Z, Zhenzhou J. Hepatotoxicity mechanisms of isoniazid: A mini-review: Hepatotoxicity mechanisms of isoniazid: A mini-review. J Appl Toxicol 2015;35:1427-32. [DOI: 10.1002/jat.3175] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
2 Xiong K, Cai J, Liu P, Wang J, Zhao S, Xu L, Yang Y, Liu J, Ma A. Lactobacillus casei Alleviated the Abnormal Increase of Cholestasis-Related Liver Indices During Tuberculosis Treatment: A Post Hoc Analysis of Randomized Controlled Trial. Mol Nutr Food Res 2021;65:e2100108. [PMID: 33864432 DOI: 10.1002/mnfr.202100108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hassan HM, Guo H, Yousef BA, Ping-Ping D, Zhang L, Jiang Z. Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress. Front Pharmacol 2017;8:133. [PMID: 28360859 DOI: 10.3389/fphar.2017.00133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Niknahad H, Heidari R, Firuzi R, Abazari F, Ramezani M, Azarpira N, Hosseinzadeh M, Najibi A, Saeedi A. Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats. Adv Pharm Bull. 2016;6:617-625. [PMID: 28101469 DOI: 10.15171/apb.2016.076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
5 Shen Q, Wang J, Yuan Z, Jiang Z, Shu T, Xu D, He J, Zhang L, Huang X. Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis. Int Immunopharmacol 2019;77:105959. [PMID: 31644961 DOI: 10.1016/j.intimp.2019.105959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med 2018. [PMID: 29806961 DOI: 10.1111/joim.12780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
7 Pan Y, Cao M, You D, Qin G, Liu Z. Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives. Biomed Res Int 2019;2019:1283824. [PMID: 31119149 DOI: 10.1155/2019/1283824] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kojovic D, Piquette-miller M. Regulation of Drug Transporters by Inflammation. Drug Metabolism in Diseases. Elsevier; 2017. pp. 59-89. [DOI: 10.1016/b978-0-12-802949-7.00003-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Heidari R, Ahmadi F, Rahimi HR, Azarpira N, Hosseinzadeh M, Najibi A, Niknahad H. Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice. Drug Chem Toxicol 2019;42:615-23. [PMID: 29722569 DOI: 10.1080/01480545.2018.1459668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Yang N, Sun R, Zhao Y, He J, Zhen L, Guo J, Geng J, Xie Y, Wang J, Feng S, Fei F, Liao X, Zhu X, Wang H, Fu F, Aa J, Wang G. High fat diet aggravates the nephrotoxicity of berberrubine by influencing on its pharmacokinetic profile. Environmental Toxicology and Pharmacology 2016;46:319-27. [DOI: 10.1016/j.etap.2016.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hassan HM, Yousef BA, Guo H, Xiaoxin L, Zhang L, Jiang Z. Investigating the CYP2E1 Potential Role in the Mechanisms Behind INH/LPS-Induced Hepatotoxicity. Front Pharmacol 2018;9:198. [PMID: 29563874 DOI: 10.3389/fphar.2018.00198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ho SS, McLachlan AJ, Chen TF, Hibbs DE, Fois RA. Relationships Between Pharmacovigilance, Molecular, Structural, and Pathway Data: Revealing Mechanisms for Immune-Mediated Drug-Induced Liver Injury. CPT Pharmacometrics Syst Pharmacol 2015;4:426-41. [PMID: 26312166 DOI: 10.1002/psp4.56] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Hassan HM, Guo H, Yousef BA, Guerram M, Hamdi AM, Zhang L, Jiang Z. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment. Antimicrob Agents Chemother 2016;60:5285-93. [PMID: 27324775 DOI: 10.1128/AAC.00854-16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]